Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 16, 2023 - Issue
Submit an article Journal homepage
185
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Correlation Between C-Peptide and Severity of Peripheral Atherosclerosis in Type 2 Diabetes Mellitus

Maisa A Wahab1 Department of Vascular Surgery, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0001-6190-1230
ORCID Icon,
Alshaymaa M Alhabibi2 Department of Clinical Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3858-4649
ORCID Icon,
Ahmed Khairy Sakr1 Department of Vascular Surgery, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
,
Mohamed Yahia Zakaria3 Department of Vascular and Endovascular Surgery, Faculty of Medicine for Boys, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0002-0810-1266
ORCID Icon,
Ola I Saleh4 Department of Radio-Diagnosis, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
,
Inass Hassan Ahmad5 Department of Endocrinology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0003-0067-9490
ORCID Icon,
Eman Kamel Abdelrahman6 Department of Internal Medicine, Faculty of Medicine, Port Said University, Port Said, Egypt
,
Randa Sabour Elshahat Taha4 Department of Radio-Diagnosis, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
,
Fayka Karem Abdel Azeem Ahmed4 Department of Radio-Diagnosis, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0002-0410-8794
ORCID Icon,
Bothayna Ismail2 Department of Clinical Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
,
Lamiaa Hosney Azel5 Department of Endocrinology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
,
Asmaa S Hassan2 Department of Clinical Pathology, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0002-0970-2426
ORCID Icon,
Hanaa Mohammed Eid El Sayed7 Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0001-8513-2333
ORCID Icon,
Sammar Ahmed Kasim7 Department of Internal Medicine, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0001-7477-8833
ORCID Icon &
Safaa Abdelfattah Elsharkawy8 Department of Community Medicine and Occupational Health, Faculty of Medicine for Girls, Al-Azhar University, Cairo, EgyptORCID Iconhttps://orcid.org/0000-0002-5569-5554
ORCID Icon show all
Pages 2617-2625 | Received 11 Jul 2023, Accepted 21 Aug 2023, Published online: 29 Aug 2023

References

  • Guideline of American Diabetes Association. Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care. 2016;39(1):S4–5. PMID: 26696680. doi:10.2337/dc16-S003
  • Hegazi R, El-Gamal M, Abdel-Hady N, Hamdy O. Epidemiology of and risk factors for type 2 diabetes in Egypt. Ann Global Health. 2015;81(6):814–820. PMID: 27108148. doi:10.1016/j.aogh.2015.12.011
  • Gerbo RM, Jin CF, Clark K. Diabetes in the workplace: the hazards of hypoglycemia. Curr Diab Rep. 2019;19(11):119. PMID: 31686223. doi:10.1007/s11892-019-1234-2
  • Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl):S35–42. PMID: 19179216; PMCID: PMC2663393. doi:10.1016/j.jacc.2008.09.055
  • Basyouni MW, Shabana AM, El Kilani WM. Prevalence of lower extremities peripheral arterial disease among Egyptian ischemic patients attending cardiac rehabilitation unit. Egypt Heart J. 2018;70(4):295–299. PMID: 30591746; PMCID: PMC6303360. doi:10.1016/j.ehj.2018.06.005
  • Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther. 2008;88(11):1322–1335. PMID: 18801863; PMCID: PMC2579903. doi:10.2522/ptj.20080008
  • Nathan DM, Genuth S, Lachin J, et al.; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. PMID: 8366922. doi:10.1056/NEJM199309303291401
  • Turner Robert C, Fox C. “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group”. Lancet. 1998;352:837–853.
  • Bahtt MP, Lim Y, Ha K. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovasc Res. 2014;104(2):234–244. PMID: 25239825. doi:10.1093/cvr/cvu211
  • Reaven PD, Emanuele NV, Wiitala WL, et al. VADT Investigators. Intensive glucose control in patients with type 2 diabetes - 15-year follow-up. N Engl J Med. 2019;380(23):2215–2224. PMID: 31167051; PMCID: PMC6706253. doi:10.1056/NEJMoa1806802
  • Shaw JA, Shetty P, Burns KD, Fergusson D, Knoll GA. C-Peptide as a therapy for kidney disease: a systematic review and meta-analysis. PLoS One. 2015;10(5):e0127439. PMID: 25993479; PMCID: PMC4439165. doi:10.1371/journal.pone.0127439
  • Yosten GL, Maric-Bilkan C, Luppi P, Wahren J. Physiological effects and therapeutic potential of proinsulin C-peptide. Am J Physiol Endocrinol Metab. 2014;307(11):E955–68. PMID: 25249503; PMCID: PMC4254984. doi:10.1152/ajpendo.00130.2014
  • Polonsky KS. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes. 1995;44(6):705–717. PMID: 7789637. doi:10.2337/diab.44.6.705
  • Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes. 1990;39(12):1527–1533. PMID: 2245877. doi:10.2337/diab.39.12.1527
  • Standl E, Janka HU. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res Suppl. 1985;15:46–51. PMID: 3908281.
  • Alves MT, Ortiz MMO, Dos Reis GVOP, et al. The dual effect of C-peptide on cellular activation and atherosclerosis: protective or not? Diabetes Metab Res Rev. 2019;35(1):e3071. PMID: 30160822. doi:10.1002/dmrr.3071
  • Patel N, Taveira TH, Choudhary G, Whitlatch H, Wu WC. Fasting serum c peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2012;1(6):e003152. doi:10.1161/JAHA.112.003152
  • Abdullah A, Hasan H, Raigangar V, Bani-Issa W. C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females. Int J Endocrinol. 2012;2012:420792. PMID: 22899917; PMCID: PMC3415197. doi:10.1155/2012/420792
  • Harnishsingh B, Rama B. Is C-peptide a predictor of severity of coronary artery disease in metabolic syndrome? An observational study. Indian Heart J. 2018;70(Suppl 3):S105–S109. PMID: 30595240; PMCID: PMC6309290. doi:10.1016/j.ihj.2018.07.005
  • Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G. Relationship of residual beta-cell function, metabolic control and chronic complications in type 2 diabetes mellitus. Acta Diabetol. 2000;37(3):125–129. PMID: 11277312. doi:10.1007/s005920070014
  • Sari R, Balci MK. Relationship between C peptide and chronic complications in type-2 diabetes mellitus. J Natl Med Assoc. 2005;97(8):1113–1118. PMID: 16173326; PMCID: PMC2575980.
  • Kim BY, Jung CH, Mok JO, Kang SK, Kim CH. Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients. Acta Diabetol. 2012;49:9–15. PMID: 21212993. doi:10.1007/s00592-010-0249-6
  • Wahren J, Shafqat J, Johansson J, Chibalin A, Ekberg K, Jornvall H. Molecular and cellular effects of C-peptide: new perspectives on an old peptide. Exp Diabesity Res. 2004;5:15–23. PMID: 15198368; PMCID: PMC2478619. doi:10.1080/15438600490424479
  • Son SM. C-Peptide and vascular complications in type 2 diabetic subjects. Diabetes Metab J. 2012;36(5):345–349. PMID: 23130318; PMCID: PMC3486980. doi:10.4093/dmj.2012.36.5.345
  • Kim ST, Kim BJ, Lim DM, et al. Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J. 2011;35(1):41–49. PMID: 21537412; PMCID: PMC3080577. doi:10.4093/dmj.2011.35.1.41
  • Wang L, Lin P, Ma A, et al. C-peptide is independently associated with an increased risk of coronary artery disease in T2DM subjects: a cross-sectional study. PLoS One. 2015;10(6):e0127112. PMID: 26098780; PMCID: PMC4476669. doi:10.1371/journal.pone.0127112
  • Yan ST, Sun J, Gu ZY, et al. The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(201). doi:10.1186/s12933-022-01636-z
  • Thippeswamy T, Nithin N, Chikkegowda P. An association of fasting C-peptide levels and vascular complications in chronic type 2 diabetes mellitus patients. J Clin Diagn Res. 2021;15(2):OC10–OC13. doi:10.7860/JCDR/2021/47265.14506

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.